Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Lei Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9995-9080; OpenAlex author ID A5100349606. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tum… First author DOI 10.3389/fgene.2022.853471↗
  2. Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Co-author DOI 10.1038/onc.2013.223↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pengwei Cao · 1 shared paper, 2022 · strength 0.20
  2. Fubao Liu · 1 shared paper, 2022 · strength 0.20
  3. W-Q Wang · 1 shared paper, 2014 · strength 0.04
  4. B. Zhang · 1 shared paper, 2014 · strength 0.04
  5. C. Liu · 1 shared paper, 2014 · strength 0.04
  6. Xianjun Yu · 1 shared paper, 2014 · strength 0.04
  7. Yi Qin · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.